$5 million grant to fund saliva tests for students, teachers, staff in schools operated by Special School District of St. Louis County
Young people with disabilities focus of COVID-19 testing grant
Category: Research
Fluvoxamine may prevent serious illness in COVID-19 patients
Antidepressant drug repurposed for patients with coronavirus infection
Uncovering genetic roots of marijuana use disorder
As more states enact laws legalizing pot, addiction problems may increase
College students access eating disorders therapy via phone app
Multi-university study shows app can help students reduce symptoms, ease depression
African American children with autism experience long delays in diagnosis
Such delays lead to serious disparities in access to developmental therapy
Nasal Spray Is A New Antidepressant Option For People At High Risk of Suicide
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.
$13.7 million to further adolescent brain development study
Grant from National Institute on Drug Abuse to extend landmark study
Potential biomarker for autism identified in infants
Low levels of neuropeptide in babies’ cerebrospinal fluid linked to later diagnosis.
WashU to test OCD drug for potential COVID-19 treatment
Researchers at Washington University School of Medicine are recruiting COVID-19 patients for a clinical trial that will examine whether an existing anti-depressant can be an effective treatment for COVID-19.
Can a long-used antidepressant stop COVID-19’s deadly ‘cytokine storm’?
Eric Lenze, MD, and Caline Mattar, MD, have launched a study into whether a long-used antidepressant can reduce the likelihood that COVID-19 will turn deadly.